Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2021 Oct 25;21:1098. doi: 10.1186/s12879-021-06791-4

Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study

Julien Riou 1,, Carole Dupont 1, Silvia Bertagnolio 2, Ravindra K Gupta 3,4, Roger D Kouyos 5,6, Matthias Egger 1,7,8, Christian L Althaus 1
PMCID: PMC8543892  PMID: 34696729

Correction to: BMC Infect Dis (2021) 21:1042 https://doi.org/10.1186/s12879-021-06757-6

Following publication of the original article [1], it was noted that the Supplementary file was missing.

Additional file 1 can be found in this Correction article (Additional file 1).

The original article has been corrected as well.

Supplementary Information

12879_2021_6791_MOESM1_ESM.pdf (456.1KB, pdf)

Additional file 1. Additional details about the data and the model.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Riou J, Dupont C, Bertagnolio S, Gupta RK, Kouyos RD, Egger M, Althaus CL. Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study. BMC Infect Dis. 2021;21:1042. doi: 10.1186/s12879-021-06757-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12879_2021_6791_MOESM1_ESM.pdf (456.1KB, pdf)

Additional file 1. Additional details about the data and the model.


Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES